Stock DCPH DECIPHERA PHARMACEUTICALS, INC.
Add to a list
To use this feature you must be a member
Log inSign up

Revisions Deciphera Pharmaceuticals, Inc.

Equities

DCPH

US24344T1016

Real-time Estimate Cboe BZX
Other stock markets
 03:49:25 2024-06-10 pm EDT 		5-day change 1st Jan Change
25.58 USD +0.06% Intraday chart for Deciphera Pharmaceuticals, Inc. +0.12% +58.65%
Jun. 03 Deciphera Pharmaceuticals Announces Oral Presentation of Results from Motion Pivotal Phase 3 Study of Vimseltinib in Patients with Tenosynovial Giant Cell Tumor At the 2024 Asco Annual Meeting and Online Publication in the Lancet CI
May. 10 Deciphera Pharmaceuticals, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024 CI

Turnover - Change in analysts' estimates

Earnings Per Share (EPS) - Change in analysts' estimates

EBIT - Change in analysts' estimates

Turnover

Earnings Per Share (EPS)

EBIT

  1. Stock Market
  2. Equities
  3. DCPH Stock
  4. Revisions Deciphera Pharmaceuticals, Inc.